These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32395888)

  • 1. Methylation-mediated miR-214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN.
    Xu H; Wu S; Shen X; Shi Z; Wu D; Yuan Y; Jiang W; Wang Q; Ke Q; Mao Q; Li X; Liu Y; Yuan P; Zhang Q; Huang E; Chen X
    J Cell Mol Med; 2020 Jun; 24(11):6410-6425. PubMed ID: 32395888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
    Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
    J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Koellermann J; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2007; 28(3):132-8. PubMed ID: 17519534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
    Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y
    Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.
    Crnković-Mertens I; Wagener N; Semzow J; Gröne EF; Haferkamp A; Hohenfellner M; Butz K; Hoppe-Seyler F
    Cell Mol Life Sci; 2007 May; 64(9):1137-44. PubMed ID: 17437058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
    Oh BY; Lee RA; Kim KH
    World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.
    Chen S; Ma P; Li B; Zhu D; Chen X; Xiang Y; Wang T; Ren X; Liu C; Jin X
    Mol Cell Biochem; 2017 Oct; 434(1-2):135-142. PubMed ID: 28470345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.
    Liu C; Wu X; Luo C; Hu Z; Yin Z; He Y; Du H; Zhang W; Jiang Q; Lin Y
    J Exp Clin Cancer Res; 2010 Jun; 29(1):63. PubMed ID: 20525250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.
    Wagener N; Crnković-Mertens I; Vetter C; Macher-Göppinger S; Bedke J; Gröne EF; Zentgraf H; Pritsch M; Hoppe-Seyler K; Buse S; Haferkamp A; Autschbach F; Hohenfellner M; Hoppe-Seyler F
    Br J Cancer; 2007 Nov; 97(9):1271-6. PubMed ID: 17968430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
    Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
    Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
    Jiao D; Wu M; Ji L; Liu F; Liu Y
    Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.